Latest Tau protein Stories
Laboratory study shows drug targets chaperone Hsp70 to reduce Alzheimer's protein.
New research has shown that a rogue protein thought to cause Alzheimer's can spread through the brain, turning healthy tissue bad.
Researchers at the University of Illinois at Chicago College of Medicine have discovered a mode of action for mysterious but diagnostic protein snarls found in the brains of Alzheimer's patients that suggests a one-two punch of therapy may be needed to combat the neurodegenerative disease.
Scientists at UC Santa Barbara have discovered that a protein called BAG2 is important for understanding Alzheimer's disease and may open up new targets for drug discovery.
A Swedish researcher said on Friday that mice who were fed junk food for nine months showed signs of developing the abnormal brain tangles strongly associated with Alzheimer's disease.
SAN FRANCISCO, Aug. 20 /PRNewswire/ -- Emerging therapeutic strategies for Alzheimer's disease is the focus of the most recent edition of Neurotech Insights, the leading monthly industry newsletter covering drugs, devices and diagnostics for the brain and nervous system.
A NEW drug could prove at least twice as effective in treating Alzheimer's disease as current medicines, according to new research. The drug, rember, slows progression of the disease by asmuch as 81%, a British-led study published last night found.
By MARILYNN MARCHIONE, THE ASSOCIATED PRESS CHICAGO For the first time, an experimental drug shows promise for halting the progression of Alzheimer's disease by taking a new approach: breaking up the protein tangles that clog victims' brains.
By JANE KIRBY A new drug could prove at least twice as effective in treating Alzheimer's disease as current medicines, new research has shown. The drug, rember, slows progression of the disease by as much as 81%, a British-led study has found.
- A volcanic mudflow.